These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7974675)

  • 1. Type 1 reactions in leprosy, neuritis and steroid therapy: the impact of the human immunodeficiency virus.
    Bwire R; Kawuma HJ
    Trans R Soc Trop Med Hyg; 1994; 88(3):315-6. PubMed ID: 7974675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali.
    Lienhardt C; Kamate B; Jamet P; Tounkara A; Faye OC; Sow SO; Bobin P
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):383-91. PubMed ID: 9030103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HIV infection on the clinical spectrum of leprosy in Maiduguri.
    Moses AE; Adelowo KA; Nwankwo EA
    Niger Postgrad Med J; 2001 Jun; 8(2):74-7. PubMed ID: 11487905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term follow up of patients with multibacillary leprosy and HIV infection.
    Jacob M; George S; Pulimood S; Nathan N
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):392-5. PubMed ID: 9030104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-adherence to steroid therapy in leprosy reaction and neuritis.
    Mani S; Darlong J; John A; Govindharaj P
    Lepr Rev; 2015 Dec; 86(4):356-67. PubMed ID: 26964431
    [No Abstract]   [Full Text] [Related]  

  • 6. Does concomitant hiv infection has any epidemiological, clinical, immunopathological and therapeutic relevance in leprosy?
    Kar HK; Sharma P
    Indian J Lepr; 2007; 79(1):45-60. PubMed ID: 17578267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome.
    Trindade MA; Valente NY; Manini MI; Takahashi MD; Anjos CF; Benard G; Naafs B
    J Clin Microbiol; 2006 Dec; 44(12):4616-8. PubMed ID: 17021066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study.
    Lugão HB; Frade MA; Marques W; Foss NT; Nogueira-Barbosa MH
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005111. PubMed ID: 27851766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis.
    Serrano-Coll H; Muñoz M; Camilo Beltrán J; Duthie MS; Cardona-Castro N
    Trans R Soc Trop Med Hyg; 2017 Mar; 111(3):125-131. PubMed ID: 28633333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus and leprosy.
    Lucas S
    Lepr Rev; 1993 Jun; 64(2):97-103. PubMed ID: 8341127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interleukin-1β and interleukin-6 in leprosy reactions in patients with human immunodeficiency virus coinfection.
    Pires CAA; Quaresma JAS; de Souza Aarão TL; de Souza JR; Macedo GMM; Neto FOMJ; Xavier MB
    Acta Trop; 2017 Aug; 172():213-216. PubMed ID: 28511777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anatomopathologic study of five cases of leprosy in HIV seropositive patients].
    Faye O; Mahé A; Jamet P; Huerre M; Bobin P
    Acta Leprol; 1996; 10(2):93-9. PubMed ID: 9054200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy.
    Ranque B; Nguyen VT; Vu HT; Nguyen TH; Nguyen NB; Pham XK; Schurr E; Abel L; Alcaïs A
    Clin Infect Dis; 2007 Jan; 44(1):33-40. PubMed ID: 17143812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between leprosy and HIV infection in Tanzania.
    van den Broek J; Chum HJ; Swai R; O'Brien RJ
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):203-10. PubMed ID: 9251592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection with human immunodeficiency virus type 1 among leprosy patients in Zaire.
    Lucas SB; Fine PE; Sterne JA; Pönnighaus JM; Turner AC; De Cock KM; Zuckerman M
    J Infect Dis; 1995 Feb; 171(2):502-4. PubMed ID: 7844401
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India.
    Lockwood DN; Vinayakumar S; Stanley JN; McAdam KP; Colston MJ
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):8-15. PubMed ID: 8326184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infection by the human immunodeficiency virus and leprosy].
    Serme AK
    Med Trop (Mars); 1992; 52(3):245-50. PubMed ID: 1435184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy reactions in postelimination stage: the Bangladesh experience.
    Mowla MR; Ara S; Mizanur Rahman AFM; Tripura SP; Paul S
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):705-711. PubMed ID: 27859670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.